Grant: Jennifer Anolik, MD, PhD, and Javier Rangel-Moreno, PhD, both from Allergy, Immunology & Rheumatology, have received funding from the Lupus Research Alliance for their project "SGLT2 inhibition as a novel treatment for lupus nephritis." Their work will test the efficacy of this new class of drugs in a mouse model of lupus and an initial cohort of lupus patients for the first time.

Appointment: Dallas Nelson, MD, from Geriatrics & Aging, was appointed to Governor Hochul's Reimagining Long-Term Care Task Force. She also serves as president of the New York Medical Directors Association.

Publication: Cheryl Rozario, DO, MPH, and Jessica Stern, MD, both from Allergy, Immunology & Rheumatology, published "Outcomes of penicillin allergy delabeling by nonallergy specialists at an academic medical center," in the Journal of Allergy and Clinical Immunology: In Practice.

Publication: Ghinwa Dumyati, MD, from Infectious Diseases, is a co-author of the Morbidity and Mortality Weekly Report from the CDC, "Vital Signs: Health Disparities in Hemodialysis-Associated Staphylococcus aureus Bloodstream Infections — United States, 2017–2020."

Publication: Ann Falsey, MD, from Infectious Diseases, is the lead author of "Efficacy and Safety of an Ad26.RSV.preF–RSV preF Protein Vaccine in Older Adults," published in the New England Journal of Medicine. This study shows 80 percent effectiveness of an adult RSV vaccine in a phase 2b clinical trial.

DOM Representing at ESHOS Review of San Antonio Breast Cancer Symposium

The Empire State Hematology & Oncology Society (ESHOS) is hosting the review on Saturday, March 4 at the Del Lago Resort. This half-day event is full of interactive sessions with the nation's leading breast cancer experts, including the DOM's own Ajay Dhakal, MBBS, presenting "Advances in HER2 Positive Breast Cancer," and Ruth O'Regan, MD, presenting "Hormone Receptor-Positive Breast Cancer." View the flyer for full details.